Drug intelligence / Profile preview

manganese chloride

Development stage
Approved
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Intravenous
01

Overview

**Manganese chloride** is an inorganic manganese salt used in U.S. prescription parenteral nutrition as a trace-element supplement. The marketed Manganese Chloride Injection, USP product contains manganese chloride tetrahydrate and is added to intravenous total parenteral nutrition solutions in adults to maintain manganese concentrations and prevent manganese depletion and deficiency manifestations. Released manganese acts as an essential enzymatic cofactor for multiple manganese-dependent metalloenzymes involved in intermediary metabolism and other physiologic processes; it is not a selective receptor-targeted therapy. Excessive intravenous exposure, especially with prolonged parenteral nutrition or impaired biliary excretion, can cause manganese accumulation and neurologic toxicity. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e979070-5035-4076-e09c-b52466be3c68))

Brand names
Manganese Chloride Injection
Other names
manganese(II) chloridemanganous chloridemanganese dichloride
02

Targets

S100A8/S100A9 (S100A8/S100A9 heterodimer)

Beyond the preview

Go deeper on manganese chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on manganese chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call